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Atria1 natriuretic factor (ANF) binding sites, or ANF-induced cGMP accumulation, have been shown in numerous 
tissues that may not be intimately involved in volume homeostasis. In a series of experiments, we found that quiescent 
rat glomerular mesangial cells in culture could be reactivated to enter the cell cycle, and that ANF had potent inhibitory 
effects on proliferation of these cells. PH]Thymidine incorporation increased by fivefold in reactivated compared to quies- 
cent cells, and ANF in physiologic concentrations inhibited this incorporation by 48%. Thus, ANF appears to be a multi- 
functional peptide, consistent with a number of peptide growth factors. 
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1. INTRODUCTION 
The majority of work published on atria1 
natriuretic factor (ANF) deals with the role of the 
hormone in volume homeostasis. We have been 
impressed with the fact that ANF binding sites, or 
ANF-induced cGMP accumulation, have been 
shown in numerous tissues that may not be in- 
timately involved in volume homeostasis. For ex- 
ample, ANF binding sites exist in cultured rat lung 
fibroblasts [l], and ANF stimulates cGMP ac- 
cumulation in 3T3 fibroblasts [2] as well as 
homogenates of testis, intestine, lung and liver [3]. 
In a series of experiments, we have shown that 
quiescent rat glomerular mesangial cells in culture 
can be reactivated to enter the cell cycle, and that 
ANF has potent inhibitory effects on proliferation 
of these cells. These findings suggest that ANF 
should be considered a circulating hormone, and 
possibly an autacoid, with diverse effects on 
diverse tissues. 
Correspondence address: R.G. Appel, Department of 
Medicine, School of Medicine, East Carolina University, 
Greenville, NC 27858-4354, USA 
2. MATERIALS AND METHODS 
RPM1 1640 was purchased from Hazleton, Lenexa, KS. Fetal 
bovine serum was from HyClone, Logan, UT. Dulbecco’s 
modified Eagle’s medium and Ham’s nutrient mixture F12 
(DME/F12) was from Sigma, St. Louis, MO. [3H]Thymidine 
(spec. act. 6.7 Ci/mmol) was from New England Nuclear, 
Boston, MA. Insulin, transferrin, selenium, and fibroblast 
growth factor (FGF) were from Collaborative Research, Bed- 
ford, MA. Bovine serum albumin and soybean lipids were from 
Boehringer Mannheim, Indianapolis, IN. Atriopeptin III 
(APIII) was purchased from Bachem, Torrance, CA. 
Glomeruli were isolated from the kidneys of 100 g male 
Sprague-Dawley rats as previously described [4]. Primary 
glomerular mesangial cell strains were started from isolated 
glomeruli using the method of Lovett et al. [S]. Cells were 
grown in RPM1 1640 media containing 17% fetal bovine serum. 
Monolayers from passages l-4 were held in serum-free 
DME/F12 for 4 days since preliminary work had indicated that 
by three to four days, the cells incorporate a minimum amount 
of [‘Hlthymidine, indicating a quiescent state. A defined 
mesangial medium (DMM) including DME/FlZ plus 10 pg/ml 
insulin, lOgg/ml transferrin, 10 ng/ml selenium, 1 mg/ml 
bovine serum albumin, and 50 pg/ml soybean lipids was utiliz- 
ed to reactivate the mesangial cells. Monolayers were exposed 
to DMM plus agonists as described, plus 1 &i/ml 
[3H]thymidine for 48 h. The reaction was terminated, and DNA 
was extracted to measure [3H]thymidine incorporation by a 
slight modification of a previously described technique [6]. 
Briefly, the cells were washed to remove free [‘Hlthymidine, 
lysed and solubilized in SDS, and exposed to ice-cold 10% 
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Fig. 1. [‘H]Thymidine incorporation into DNA of cultured rat 
glomerular mesangial cells. Results represent mean + SE of 
triplicate determinations from 4-8 different cell strains. 
Numbers given in bars represent API11 concentration (M). 
Abbreviations as described in text. p < 0.05, DMM vs 
DME/FlZ, independent r-test. p < 0.05, DMM + API11 
(lo-” M-10-’ M) vs DMM, independent t-test. 
trichloroacetic acid (TCA). The particulate fraction containing 
DNA-associated [3H]thymidine was separated from free 
cytosolic counts by depositing the contents of each well onto 
glass microfibre filters, and washing with TCA. The filters were 
dried and counted. Protein was measured in representative wells 
by the Lowry method [7]. 
Results are expressed as means f SE. Statistical significance 
was determined by use of Student’s t-test for unpaired data. 
Data were considered statistically significant if p < 0.05. 
3. RESULTS 
Fig. 1 demonstrates that [3H]thymidine incor- 
poration into quiescent cells in DME/F12 was low 
at 8.5 + 1.1 cpm/pg protein. Reactivation of the 
cells by DMM increased [3H]thymidine incorpora- 
tion significantly to 46.0 f 8.4 cpm/pg protein, 
representing a greater than 5-fold increase. Addi- 
tion of the synthetic ANF peptide API11 to the 
DMM in concentrations from lo-‘* to 10m7 M 
significantly inhibited [3H]thymidine incorpora- 
tion into mesangial cells. A half-maximal response 
was seen at approximately lo-” M, representing a
concentration in the physiologic range. Addi- 
tionally, the maximal inhibitory effect, seen at 
concentrations of API11 10-i’ M and higher, was 
quite potent, averaging 48% of the total DMM- 
stimulated activity. 
Table 1 extends these findings. In cultured 
mesangial cells exposed to the growth factor FGF 
plus DMM, [3H]thymidine incorporation increased 
7-fold above quiescent values (DME/F12), and 
30% above DMM alone. Addition of API11 
significantly inhibited [3H]thymidine incorpora- 
tion in the DMM plus FGF-stimulated cells by an 
average of 49%. In summary, addition of API11 
inhibited [3H]thymidine incorporation by approx- 
imately 50% in mesangial cells incubated in DMM 
or DMM plus FGF. The added proliferative effect 
of DMM plus FGF over DMM alone was blocked 
by 50% by APIII. Therefore, these experiments in- 
dicate a lack of specificity to the inhibitory effect 
of API11 on mesangial cell growth and suggest an 
undefined common mechanism of action. 
Table 1 
t3H]Thymidine (cpm/pg protein) 
Observation DME/FlZ DMM DMM + API11 DMM + FGF DMM + FGF + API11 
1 3.5 48.0 26.7 55.2 27.0 
2 8.8 38.0 21.0 44.9 22.5 
3 7.8 34.3 15.8 40.3 20.6 
4 7.4 44.8 20.8 56.3 29.3 
5 6.6 34.7 18.1 57.6 30.5 
6 8.0 35.2 18.8 50.4 27.2 
Mean f SE 7.0 rt 0.8 39.2 k 2.4a 20.2 f 1.5b 50.8 + 2.8’ 26.2 k 1.6d 
a p < 0.05 vs DME/FlZ, independent t-test 
b p < 0.05 vs DMM, independent t-test 
’ p < 0.05 vs DMM, independent t-test 
d p < 0.05 vs DMM + FGF, independent t-test 
[‘H]Thymidine incorporation into DNA of cultured rat glomerular mesangial cells. Results 
represent observations from 2 separate cell strains. FGF concentration 100 ng/ml. API11 
concentration lo-’ M. Abbreviations as described in text 
136 
Volume 238, number 1 FEBS LETTERS September 1988 
Table 2 
[3H]Thymidine (cpm/well) 
Condition Total cell- DNA- 
associated associated 
DME/FlS 1168 * 189 254 k 41 
DMM 5454 i 645 1558 + 184 
DMM + API11 (10-s M) 5966 + 606 810 + 93 
Results represent he mean + SE of triplicate determinations 
from 3 separate experiments. DNA-associated counts 
determined as described in section 2. Total cell-associated 
counts determined by counting entire solubilized cell fraction. 
Abbreviations as described in text 
It was important to show that inhibitory effects 
of ANF on [3H]thymidine incorporation truly 
reflect inhibition of DNA synthesis and not simply 
inhibition of active transport of the thymidine 
through the cell membrane [8]. Therefore, ex- 
periments were designed to measure not only 
DNA-associated [3H]thymidine, but also total cell- 
associated [3H]thymidine. Table 2 summarizes 
these data. As expected, there was an excess of 
total cell-associated versus DNA-associated 
[3H]thymidine. The important finding, however, 
was that in the presence of DMM plus APIII, there 
was no reduction in total counts compared to 
DMM alone. Only DNA counts fell. This argues 
against an inhibitory effect of ANF on active 
transport of thymidine into the cell, and argues for 
an inhibitory effect of ANF on DNA synthesis. 
4. DISCUSION 
The results described in this report demonstrate 
the novel finding that ANF is an inhibitor of 
mesangial cell proliferation. These cells are of in- 
terest in this regard since they are involved in pro- 
liferative glomerular diseases, and also have 
properties in common with vascular smooth mus- 
cle cells as well as macrophages [9]. In addition, 
the mesangial cell is clearly a target site for ANF 
[4, lo]. An extensive review of the literature reveal- 
ed very little on the subject of ANF and cell 
growth. A 1986 study revealed that ANF suppress- 
ed basal and growth hormone-releasing factor- 
stimulated secretion of growth hormone from 
anterior lobe cells of rat pituitary [ll]. These 
findings could suggest an indirect role for ANF in 
cell growth via the regulation of growth hormone 
secretion. ANF was found to stimulate 
[3H]thymidine incorporation into the DNA of 
bovine adrenal glomerulosa cells in culture [ 121, 
suggesting a growth-stimulating effect of ANF on 
adrenal zona glomerulosa cells. Contrary to these 
findings, an in vivo infusion of ANF induced 
atrophy of zona glomerulosa cells of rat adrenals 
[ 131, indicating that ANF exerted inhibitory effects 
on growth of rat zona glomerulosa. It will be im- 
portant to document whether the growth in- 
hibitory properties of ANF are widely distributed 
in mammalian cells. 
The present work does not clarify the cellular 
mechanisms by which ANF inhibits growth. One 
might speculate that previously defined effects of 
ANF on cellular physiology may be involved. For 
example, ANF has been shown to stimulate cGMP 
accumulation [4] and lower free cytosolic calcium 
[lo] in mesangial cells. It is therefore of interest 
that cGMP may modify cell proliferation [ 141, and 
that various growth factors cause an elevation of 
cytosolic free calcium [ 151. 
The natriuretic, vasorelaxant, and growth- 
inhibitory effects of ANF indicate that ANF is a 
multifunctional peptide, consistent with a number 
of peptide growth factors [16]. There is an increas- 
ing body of information relating growth promoters 
and growth inhibitors to inflammatory and pro- 
liferative diseases. For example, the ability of 
platelet derived growth factor to stimulate migra- 
tion and proliferation of smooth muscle cells in 
culture has suggested that this growth factor may 
be important in the process of atherosclerosis [ 171. 
In addition, loss of responsiveness to or failure to 
produce growth inhibitors such as transforming 
growth factor-p may contribute to cancer develop- 
ment [18]. Therefore, the present work may have 
relevance to pathophysiologic processes involving 
cellular proliferation and inflammation. 
Acknowledgemenr: The author thanks MS Terry Elderkin for 
secretarial assistance. 
REFERENCES 
[l] Leitman, D.C., Agnost, V.L., Tuan, J.J., Andresen, 
J.W. and Murad, F. (1987) Biochem. J. 244, 69-74. 
[2] Appel, R.G. and Dunn, M.J. (1985) Trans. Assoc. Am. 
Phys. 98, 85-91. 
137 
Volume 238, number 1 FEBS LETTERS September 1988 
[3] Waldman, S.A., Rapoport, R.M. and Murad, F. (1984) J.
Biol. Chem. 259, 14332-14334. 
[4] Appel, R.G., Wang, J., Simonson, MS. and Dunn, M. J. 
(1986) Am. J. Physiol. 251, Fl036-F1042. 
[5] Lovett, D.H., Sterzel, R.B., Kashgarian, M. and Ryan, 
J.L. (1983) Kidney Int. 23, 342-349. 
[6] Arnqvist, H.J., Ballermann, B.J. and King, G.L. (1988) 
Am. J. Physiol. 254, C411-C416. 
[7] Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, 
R.J. (1951) J. Biol. Chem. 193, 265-275. 
[8] Grunicke, H., Hirsch, F., Wolf, H., Batter, U. and 
Kiefer, G. (1975) Exp. Cell Res. 90, 357-364. 
[9] Striker, GE. and Striker, L.J. (1985) Lab. Invest. 53, 
122-131. 
[II] Shibasaki, T., Naruse, M., Yamauchi, N., Masuda, A., 
Imaki, T., Naruse, K., Demura, H., Ling, N., Inagami, 
T. and Shizume, K. (1986) Biochem. Biophys. Res. Com- 
mun. 135, 1035-1041. 
1121 Horiba, N., Normura, K., Saito, Y., Demura, H. and 
Shizume, K. (1985) Biochem. Biophys. Res. Commun. 
132, 261-263. 
[13] Mazzocchi, G., Rebuffat, P. and Nussdorfer, G.G. (1987) 
J. Steroid Biochem. 28, 643-646. 
[14] Maca, R.D. (1984) Immunopharmacology 8, 53-60. 
[ 151 Moolenaar, W.H., Tertoolen, L.G. J. and De Laat, S. W. 
(1984) J. Biol. Chem. 259, 8066-8069. 
[16] Sporn, M.B. and Roberts, A.B. (1988) Nature 332, 
217-219. 
[lo] Appel, R.G., Dubyak, G.R. and Dunn, M.J. (1987) FEBS [17] Antoniades, H.N. and Owen, A.J. (1982) Annu. Rev. 
Lett. 224, 396-400. Med. 33, 445-463. 
[18] Marx, J.L. (1988) Science 239, 975-976. 
138 
